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ABSTRACT
The Sca-1 cell surface glycoprotein is used rou-
tinely as a marker of adult hematopoietic stem cells
(HSCs), allowing a >100-fold enrichment of these rare
cells from the bone marrow of the adult mouse. The
Sca-1 protein is encoded by the Ly-6A/E gene, a small
4-exon gene that is tightly controlled in its expression
in HSCs and several hematopoietic cell types. For the
ability to sort and localize HSCs directly from the
mouse, we initiated a transgenic approach in which we
created Ly-6A (Sca-1) green fluorescent protein (GFP)
transgenic mice. We show here that a 14-kb Ly-6A
expression cassette directs the transcription of the
GFP marker gene in all functional repopulating HSCs
in the adult bone marrow. A >100-fold enrichment of
HSCs occurred by sorting for the GFP-expressing cells.
Furthermore, as shown by fluorescence-activated cell
sorting and histologic analysis of several hematopoietic
tissues, the GFP transgene expression pattern generally
corresponded to that of Sca-1. Thus, the Ly-6A GFP
transgene facilitates the enrichment of HSCs and pre-
sents the likelihood of identifying HSCs in situ. Stem
Cells 2002;20:514-521
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INTRODUCTION
During adult stages, the hematopoietic system is con-
stantly renewed from rare hematopoietic stem cells (HSCs)
harbored in the bone marrow. HSCs can be retrospectively
identified based on their functional repopulation properties
observed only by transplantation into hematopoietic-
depleted adult recipients. The properties that define HSCs
are long-term, high-level repopulation of all hematopoietic
lineages and the ability to self-renew [1, 2].
Using the transplantation assay to identify stem cells,
HSCs have been enriched and characterized by flow cyto-
metric sorting using a wide range of antibodies detecting
cell-surface markers. The established surface marker profile of
adult HSCs is high expression of c-kit and Sca-1, low expres-
sion of Thy-1, and an absence (or very low expression) of
mature lineage markers, including CD3, CD4, and CD8 for 
T lymphocytes, B220 for B lymphocytes, Mac-1 for
macrophages, and Gr-1 for granulocytes [3-5]. This sorting
procedure has been verified by many laboratories and has been
used to sort HSCs to relative homogeneity [6]. However, it is
still unclear whether the use of antibody-mediated cell sorting
has any activating effect on HSCs, since, for example, in lym-
phocytes, antibody-mediated cross-linking of some cell-sur-
face proteins results in cell proliferation and/or differentiation.
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Sca-1, a glycoprotein-I-linked cell-surface glycopro-
tein, was one of the first epitopes used for antibody-medi-
ated enrichment of murine HSCs. Spangrude et al. [3] used
the Sca-1-specific monoclonal E13-161.7 antibody [7] for
sorting HSCs from adult murine bone marrow to yield
about a 100-fold enrichment of these cells [3, 4]. Since
then, others have used Sca-1 as a marker for enrichment of
embryonic day 14 (E14) fetal liver and E11 yolk sac HSCs
[8]. While the Sca-1 antibody is useful for enrichment of
viable HSCs, immunostaining of tissue sections, particu-
larly from embryos, has been difficult. Hence, to more
specifically localize Sca-1+ cells in embryonic tissues and
adult bone marrow, a transgenic approach with the gene
encoding Sca-1 has been taken.
The Sca-1 epitope is encoded by the strain-specific Ly-
6E/A allelic gene [9]. Examination of the specific expres-
sion pattern of Ly-6E/A has been difficult [9-11], since the
Ly-6 gene family consists of at least 18 highly homologous
cross-hybridizing genes [12, 13]. However, it was found
that the Ly-6A and Ly-6E proteins differ in their expression
pattern on marrow-repopulating cells, with Ly-6A strains of
mice expressing Sca-1 on 99% and Ly-6E strains express-
ing Sca-1 on 25% of such cells [11]. Nonetheless, the Sca-
1 marker has proven useful in identifying HSCs, and the
small size of the Ly-6A/E locus and flanking transcriptional
regulatory elements make it useful in directing marker gene
expression in HSCs in transgenic mice.
The transcriptional regulatory elements and 5′ and 3′
DNaseI hypersensitivity patterns of Ly-6E and Ly-6A have
been examined and appear to be similar [14-17]. Deletional
studies show that the 3′ flanking regions contain two hyper-
sensitive sites, which are most likely responsible for high-
level, γ-interferon-induced expression in vitro [18, 19].
This distal flanking element is also responsible for high-
level, tissue-specific expression of a lacZ marker gene in
transgenic mice [20, 21]. HSCs can be enriched from adult
bone marrow based on lacZ transgene expression [20, 21].
However, not all HSCs are located within the lacZ-express-
ing population. Whether this is a result of the lacZ marker
gene, the Ly-6A/E expression cassette, or the fluorescein di-
β-D-galactopyranoside (FDG) substrate staining method
[22] is uncertain.
Thus, to further examine, identify, and localize HSCs in
the adult mouse, we created transgenic mice with a green
fluorescent protein (GFP) gene within the context of the
Ly-6A expression cassette. We report here that all bone
marrow HSCs were positive for expression of GFP from the
Ly-6A transgene. Ly-6A GFP was also expressed in other
Sca-1+ hematopoietic cells, and histological analyses
revealed an interesting pattern of expression of GFP within
the thymus, bone marrow, and spleen cells, suggestive of
hematopoietic and endothelial cell expression. Thus, the 
Ly-6A GFP transgene marker facilitated the enrichment of
functional adult repopulating HSCs and their identification
in situ.
MATERIALS AND METHODS
Transgenic Mice
The 14-kb Ly-6A cassette (pLy-6A14) was constructed
as described previously [18, 21]. The enhanced GFP
(EGFP) gene AgeI/AflII fragment containing simian virus
40 polyA in pEGFP-N1 (Clontech; Alphen aan den Rijn,
The Netherlands; http://www.clontech.com/index.shtml)
was modified, converting 3′ and 5′ AgeI/AflII sites to Nar1
sites using oligonucleotide adaptors. The 970-bp EGFP
Nar1 fragment was cloned into pLy-6A14 to generate
pLAG.
Fertilized (C57BL/10 × CBA)F1 oocytes were microin-
jected with a 15-kb BamH1 fragment containing the Ly-6A
GFP gene from pLAG (Fig. 1A). This fragment was gel
purified for removal of all vector sequences. Positive
founder animals were bred with (C57BL/10 × CBA)F1
mice, and lines were maintained as heterozygotes.
Polymerase chain reaction (PCR) analysis of tail DNA was
used to identify founder transgenic mice. Animals were
housed according to institutional guidelines, with free
access to food and water. Animal procedures were carried
out in compliance with the Standards for Humane Care and
Use of Laboratory Animals.
DNA and RNA Analysis
Genomic DNA (5-10 µg) for Southern blot analysis
[20] was digested with BamH1 and electrophoresed
through 1% agarose/Tris, acetate, EDTA gels prior to trans-
fer to Hybond-N membranes. Transgene copy number con-
trols were generated by addition of appropriate amounts of
pLAG to nontransgenic genomic DNA. Filters were probed
with GFP and Thy-1 gene fragments. Normalization for
DNA content of each lane was performed after phosphor-
imaging analysis of Thy-1 signal. Copy number was deter-
mined subsequently by comparing the GFP signal obtained
from the transgenic mice with that of the plasmid controls
on the linear portion of the standard curve.
Total cellular RNA for Northern blot analysis was pre-
pared using the lithium chloride/urea method, and 5-15 µg
was fractionated on 1% agarose/formaldehyde gels [23]
prior to transfer to Hybond-N membranes. Filters were
probed with GFP and Ly-6E cDNA fragments. Probes used
for hybridization to Southern or Northern filters were
labeled by a random oligonucleotide priming procedure,
incorporating 32P ATP. The fragments used were as follows:
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(970 bp PCR EGFP products from pLAG); 1.2 kb Xba1-
Nru1 Thy-1 gene fragment from pD7 [24]; 761 bp EcoR1
Ly-6E cDNA fragment from pLy6.1-2R [13]. After
hybridization, filters were washed to a stringency of 0.2 ×
standard saline citrate/0.1% SDS and exposed to a phospho-
rimager screen for quantitation using Imagequant software.
Genomic DNA (200 ng) from the peripheral blood of
transplant recipients was analyzed by PCR using oligonu-
cleotide primers for GAPDH-specific sequences, (GAPDH1)
5′CTTCACCACCATGGAGAAGG 3′ and (GAPDH2) 5′CC
ACCCTGTTGCTGTAGCC 3′, and for GFP-specific
sequences, (Ly6GFP) 5′GACAGAACTTGCCACTGTGC
3′ and (GFP) 5′AAGAAGATGGTGCGCTCCTG 3′.
DNA was subjected to an initial 5 minute denaturation
at 94°C followed by 30 cycles of denaturation (1 minute at
94°C), annealing (2 minutes at 55°C), and elongation 
(2 minutes at 72°C). Serial dilutions of blood DNA from a
transgenic animal were used as a control to evaluate the
levels of donor cell reconstitution in transplanted mice.
Analysis of Long-Term Multilineage Repopulating Activity
Bone marrow cells were isolated from the femurs and
tibias of adult transgenic mice and sorted for GFP expression
on a FACSVantage (Becton Dickinson; San Jose, CA;
http://www.bd.com), and sorted adult bone marrow cells (in
limiting dilution) were assayed for the presence of HSCs by
intravenous transfer into irradiated adult recipients, as
described [25, 26]. Briefly, (C57BL/10 × CBA)F1 male
recipients were exposed to a split dose of 900 rad of gamma-
irradiation from a 137Cs source. Recipient mice were bled at
1 and >4 months after transfer and analyzed for percentage
donor contribution by donor marker-specific PCR on DNA
isolated from peripheral blood [20, 25, 26]. Reconstitution
was evaluated by ethidium bromide staining of agarose gels,
and in some cases, by Southern blot hybridization, as
described previously [25-27]. To test for long-term multilin-
eage hematopoietic repopulation, genomic DNA was iso-
lated from peripheral blood, thymus, lymph node, sorted
splenic B and T cells, and bone marrow myeloid and lym-
phoid cells. Percentage donor-cell contribution was analyzed
by PCR, and in some cases, by Southern blot hybridization
and phosporimaging.
Fluorescent Antibody Surface Staining and Flow Cytometry
All antibodies used in flow cytometric sorting and
analysis were obtained from PharMingen (Alphen aan den
Rijn, The Netherlands; http://www.bdbiosciences.com/
pharmingen). The monoclonal antibodies used were directly
conjugated with either phycoerythrin (PE) or biotin and
included: PE-anti-c-kit, PE-anti-Sca-1, PE-anti-CD4, PE-
anti-CD8, PE-anti-B220, PE-anti-Mac, and biotinylated
CD31 and CD34. Single-cell suspensions were prepared as
described [21]. After incubation with specific antibodies for
30 minutes on ice, cells were washed twice and incubated
with PE-conjugated streptavidin (Caltag Laboratories;
Burlingame, CA; http://www.caltag.com) when required.
Labeled cells were finally washed twice and filtered through
a nylon mesh screen prior to sorting. One µg/ml Hoechst
33258 or 2 µg/ml 7 amino-actinomycin D were added to
identify dead cells. To determine the background levels,
cells were stained with fluorochrome-conjugated
immunoglobulin isotype controls from Pharmingen. During
the entire staining procedure, phosphate-buffered saline
(PBS) containing 10% fetal calf serum and penicillin/
Figure 1. Ly-6A GFP transgene construct and transgenic mouse charac-
terization. A) A schematic drawing of the 14-kb BamHI fragment of the Ly-
6A gene and the insertion of the EGFP gene into the Cla1 cloning site.
Restriction sites are indicated. B = BamH1, BG = BglII, K = Kpn1, R =
EcoR1, H = HindIII, and X = Xba1. B) Southern blot analysis of DNA from
two Ly-6A GFP transgenic lines, G5 and G6, and a nontransgenic control
(NTg). Copy controls are nontransgenic DNA with Ly-6A GFP plasmid DNA
added at 1, 5, and 10 copy equivalents. After hybridization with GFP and Thy-
1 gene probes, the intensity of signal was determined by phosphorimaging. C)
Northern blot analysis of total RNA from kidney (K), bone marrow (B), and
muscle (M) of an adult G5 transgenic and a nontransgenic (NTg) littermate.
Hybridization was performed with a GFP gene and Ly-6E cDNA probes, and
the 28S RNA signal was used for RNA quantitation.
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streptomycin was used. Cells were sorted using a
FACSVantage SE (Becton-Dickinson); the purity of the
sorted cells ranged from 89%-98%. Analyses were performed
on a FACScan.
Cryosectioning and Histology
Tissues (kidney, bone marrow, spleen, lymph nodes, thy-
mus, and brain) from adult Ly-6A GFP mice were isolated and
fixed for 1 hour at room temperature in 2% paraformalde-
hyde/PBS. Tissues were equilibrated in 20% sucrose/PBS
overnight at 4°C, quick frozen in tissue tek, and stored in liq-
uid nitrogen until cryosectioning. 10-µm thick sections were
placed on glass slides, air-dried and mounted with vectashield
(Vector Laboratories; Burlingame, CA; http://www.vector
labs.com).
RESULTS
Generation of Ly-6A GFP Transgenic Mice
To provide a means by which HSCs could be enriched
without the use of antibodies or FDG (β-galactosidase sub-
strate) and to facilitate in vivo HSC localization, we gener-
ated transgenic mice expressing the GFP reporter gene
under the control of the Ly-6A gene regulatory sequences.
Since our previous results with Ly-6A
transgenic embryos showed incom-
plete expression of the inserted lacZ
marker in bone marrow HSCs [20,
21], we sought to alleviate a possible
experimentation problem (due to cell
permeabilization necessary for FDG
substrate entry into these cells) by
using the GFP reporter gene. The
enhanced GFP gene was inserted into
the Cla1 cloning site of the first
untranslated exon of Ly-6A (Fig. 1A)
and was flanked by 4 kb of upstream
and 10 kb of downstream genomic
sequences containing regulatory ele-
ments necessary for high-level spe-
cific expression in adult bone marrow
HSCs. Transgenic mice were generated, and mice from line
G5, containing eight copies of transgene (hemizygous),
were used in all the studies described here (Fig. 1B). As
expected from other published studies [20, 21], Northern
blot analysis of adult tissues revealed high-level transgene
expression in the kidney (Fig. 1C). Low-level transgene
expression was found in the bone marrow, and limited or no
expression was found in muscle tissue. Thus, the Ly-6A GFP
transgene produced a restricted expression pattern similar 
to that found previously in Ly-6A lacZ and Ly-6E lacZ
transgenic mice [20, 21].
Ly-6A GFP Expression in Tissues and Subsets of Hematopoietic
Cells of Adult Transgenic Mice
Previously, it was shown, by immunostaining of sectioned
adult hematopoietic tissues, that Sca-1 is expressed on some
cells of the thymus, spleen, and lymph nodes [28]. Sca-1 is
also expressed in the brain vasculature and the cortical tubules
of the kidney [9, 29]. Hence, histologic sections from the
hematopoietic tissues of Ly-6A GFP adult mice were exam-
ined for transgene expression under a fluorescence micro-
scope. As shown in Figure 2, GFP signal was detected in some
of the cells of the kidney (D), bone marrow (E), spleen (F),
lymph nodes (G), thymus (H), and brain (I). Within the kidney,
Figure 2. Histologic sectioning and
microscopy of Ly-6A GFP hematopoietic
tissues. Brightfield and fluorescent images,
respectively, of kidney (A and D), bone mar-
row (B and E), spleen (C and F), lymph
node (G and J), thymus (H and K), and
brain (I and L). Tissues were cryosectioned
at a thickness of 10 microns. Images B, E,
H, K, I, and L were taken at 10× magnifica-
tion. All other images were taken at 4×
magnification.
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the cortical tubules were highly positive. The bone marrow
showed highly GFP+ endothelial cells in the vasculature and
other scattered positive cells (presumably, HSCs, some prog-
enitors, and stromal cells). In the peripheral hematopoietic tis-
sues, the GFP expression pattern appeared to be strongest in
the lymphoid areas of the spleen, in the lymph nodes, and in
the medulla of the thymus (with a few subcapsular thymus
cells also GFP+). Finally, a vascular endothelial pattern of GFP
expression was found in the brain. Thus, the general expres-
sion pattern of the Ly-6A GFP transgene was identical to the
published Sca-1 immunostaining patterns [9, 28, 29].
To determine the percentage of GFP+ cells in each of the
tissues, flow cytometric analysis was performed. All
hematopoietic tissues tested, i.e., bone marrow, thymus,
lymph node, and spleen, contained GFP+ cells (Table 1). The
lymph node contained the highest percentage (80%) of cells
expressing the GFP marker, while the bone marrow and thy-
mus contained less than 20% of GFP+ cells. Sca-1 antibody
staining of cells from each of the hematopoietic tissues
showed an overlap in the expression of GFP with the endoge-
nous Sca-1 protein. Approximately 50% or more of Sca-1+
cells in bone marrow, thymus, spleen, and lymph node were
also GFP+ (data not shown). In the lymph node, thymus, and
spleen, 40% or greater of GFP+ cells were Sca-1+. However,
in the bone marrow, a much lower percentage of GFP+ cells
were Sca-1+, suggesting that GFP was expressed more highly
or was more readily detectable than the Sca-1 antigen in the
progenitors and stem cells of this tissue.
To determine the distribution of the GFP phenotype
within hematopoietic lineages, antibodies directed against
progenitor/stem cell markers and mature lineage markers
were used in flow cytometric analyses (Table 1). In the
bone marrow, cells of all mature lineages, T cell (CD4 
and CD8), B cell (B220), and myeloid (Mac-1), and also 
progenitor/stem cells (c-kit, CD34, CD31) were GFP+.
Monocytes/granulocytes and their precursors (Mac-1+) rep-
resented the largest percentage (72%) of bone marrow cells
expressing GFP. In the thymus and lymph nodes, high per-
centages of T lymphoid cells, most notably CD4 cells, were
found to be GFP+. Cells of the myeloid lineage and the B
lymphoid lineage in the spleen were also GFP+. Thus, the
Ly-6A GFP transgene was expressed to some degree in all
hematopoietic lineages but appeared to be predominantly
expressed in mature T cells in the lymphoid organs and in
myeloid and immature hematopoietic progenitor/stem cells
in the bone marrow.
Ly-6A GFP Expression Marks All Functional Bone Marrow
HSCs
To determine whether the Ly-6A GFP transgene was
expressed in functional adult repopulating HSCs, we performed
transplantation experiments with flow cytometric-sorted cells
from adult bone marrow. A representative fluorescence profile
of bone marrow cells sorted on the basis of endogenous Sca-1
and GFP expression is shown in Figure 3A. In this profile, at
least five populations of cells are apparent; most predominant
are the Sca-1–GFP–, Sca-1–GFPlo, and Sca-1–GFPhi, and less
frequent are Sca-1+GFPlo+neg and Sca-1+GFPhi. These five pop-
ulations were sorted and injected into irradiated adult recipi-
ents at limiting dilution to test for long-term, high-level,
multilineage repopulation. At greater than 4 months posttrans-
plantation, peripheral blood DNA was tested for the presence
of the Ly-6A GFP transgene marker. Only recipients showing
greater than 10% donor cell repopulation using a semiquanti-
tative PCR method for the GFP transgene were considered
positive for HSC repopulation. The results of three indepen-
dent sorting and transplantation experiments show that all
HSC activity was found within the GFPhi fractions (Fig. 3B).
These animals were high-level, multilineage engrafted as
determined by donor marker PCR analysis of DNA from
hematopoietic tissues and sorted populations of B, T, and
myeloid cells (Fig. 3D). No HSC activity was found in the
GFPlo or GFP– fractions. Although one animal receiving 5 ×
105 Sca-1–GFP– cells was positive, this recipient was only 10%
engrafted by the donor cells, suggesting no enrichment for
HSCs compared with the whole bone marrow control. As
expected, most of the HSC activity was highly enriched in the
Sca-1+ fraction of the GFPhi cells. As few as 1,000 Sca-1+
GFPhi cells resulted in reproducibly high-level multilineage
repopulation (Fig. 3B). Limited HSC activity was also found
in the Sca-1– GFPhi fraction, but only when 105 cells were
transplanted (Fig. 3C). These results demonstrate that GFP
expression has no adverse effects on adult bone marrow HSCs
and can be used to enrich for these cells by approximately 100-
fold. Finally, these results, in combination with the expression
Table 1. Hematopoietic lineage marker expression on GFP+ cells within adult tissues
Bone marrow Thymus Lymph node Spleen
% GFP+ 15.4 10.8 80.7 26.3
Marker % marker+ cells within GFP+ population
Sca-1 13.3 40.6 65.0 69.4
c-kit 9.7 nd nd nd
CD34 8.5 nd nd nd
CD31 35.0 nd nd nd
CD4 8.9 83.1 62.1 41.8
CD8 3.0 40.9 43.7 25.4
B220 16.2 nd 22.8 48.5
Mac-1 72.0 nd nd 16.6
Abbreviation: nd = not done.
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observed in tissue sections, suggest that the GFP marker is
more highly expressed by HSCs than is Sca-1.
DISCUSSION
We have shown here that the Ly-6A GFP transgene
faithfully marks all HSCs in adult bone marrow. This is in
contrast to previous transgenic mice made with the Ly-6A
and Ly-6E expression cassettes directing the transcription
of the lacZ marker gene [20, 21]. In those mice, some HSCs
did not express lacZ. It is possible that those transgenic
HSCs were inefficiently labeled by FDG. Not all HSCs
may be sufficiently permeabilized so as to allow entry of
104103102101100
10
0
10
1
10
2
10
3
10
4
20.7%
37.3%
21.2%
3.6%4.3%
Sc
a-
1
GFP
GFPlo
100
75
50
25
0
0/30/3 0/3
0/3
2/8
0/5
1/2
Sca– population
GFP–
GFPhi
l
0/90/9
104 5 × 104 105 2.5 × 105 5 × 105
Cells injected
%
 re
ci
pi
en
ts
 re
po
pu
la
te
d
Sca+ population
GFPhi
GFPlo+neg
0/6 0/7
102 103 104
Cells injected
%
 re
ci
pi
en
ts
 re
po
pu
la
te
d
0/8
3/8
0/8
10/10
100
75
50
25
0
Pb Bm bT bM bB S sB sT Th Ln 0 1 10 100
GAPDH
GFP
DC
A B
Figure 3. A) Fluorescence profiles and gates used for sorting GFP+ and Sca-1 antibody stained Ly-6A GFP transgenic adult bone
marrow are shown. The percentages of bone marrow cells in each sorted population are indicated. B) Transplantation data from lim-
iting dilution transplantation of Sca-1+ cells within the GFPlow+neg and GFPhigh gates. The X axis shows the number of cells injected per
recipient. The bars represent the percentage of recipients found positive for donor repopulation at greater than 4 months posttrans-
plantation. The number of recipients repopulated/total number of recipients is indicated for each bar. C) Transplantation data from lim-
iting dilution transplantation of Sca-1– cells within the GFP–, GFPlow, and GFPhigh gates. The axis and bar indications are as described
for (B). Note the higher cell numbers transplanted. D) Hematopoietic multilineage analysis of a recipient repopulated with Sca-
1+GFPhigh cells. At greater than 4 months posttransplantation, DNA was isolated from peripheral blood (Pb), bone marrow (Bm), bone
marrow T cells (bT), bone marrow myeloid cells (bM), bone marrow B cells (bB), spleen (S), spleen B cells (sB), spleen T cells (sT),
thymus (Th), and lymph nodes (Ln). PCR analysis was performed using oligonucleotide primers for GFP (bottom band) and GAPDH
(top band). 0, 1, 10, and 100 were the controls indicating percentage donor cell engraftment. Transplantation results were obtained
from three independent experiments.
 by on November 14, 2006 www.StemCells.comDownloaded from 
Ma, Robin, Ottersbach et al. 520
FDG and, thus, appeared to be negative for lacZ expression.
In addition, too much permeability may allow leakage of
the substrate and again result in no or low FDG signal.
Alternatively, it may be possible that expression of the bac-
terial lacZ is regulated in transgenic mice (for purposes
such as viability) so that only low-level expression is
allowed in HSCs. Despite the incomplete isolation of bone
marrow HSCs from Ly-6E lacZ and Ly-6A lacZ transgenic
mice, the GFP marker in the Ly-6A cassette was optimally
expressed in all bone marrow HSCs and allowed the
enrichment of all HSCs. Thus, the Ly-6A cassette appears to
contain all the necessary transgene regulatory elements for
HSC-specific expression. And when used together in a
transgene context, the Ly-6A cassette and the GFP marker
are highly advantageous in maintaining a viable, unmanip-
ulated pool of HSCs in the absence of enzyme substrate
addition or antibody staining.
Is Sca-1 surface glycoprotein limiting on the surface of
some HSCs and hematopoietic cells? The expression profile
of Ly-6A GFP in adult tissues and hematopoietic cells is rem-
iniscent of the Sca-1 profile [9, 10, 28, 29], particularly in
mature hematopoietic cells of T lymphoid, B lymphoid, and
myeloid lineages. However, our fluorescence-activated cell
sorting profiles suggest that not all GFP+ cells were Sca-1+.
Indeed, the fluorescence signal produced by GFP was more
intense. This is most likely due to the fact that, within the G5
transgenic line of mice, there are eight copies of the trans-
gene, compared with the normal diploid copy number of the
endogenous Ly-6A/E gene encoding Sca-1. Furthermore,
unlike the cell-surface localization of Sca-1, which requires
extra processing steps, such as transport through the plasma
membrane, glycosylation, and GPI linkage, GFP is an easily
expressed cytoplasmic protein. Thus, GFP may be a better
marker than Sca-1 in low-expressing cells of the various
hematopoietic tissues, particularly HSCs.
Although we have not directly compared limiting dilu-
tion transplantation of Sca-1-sorted HSCs with GFP-sorted
HSCs, the general enrichment gained by Ly-6A GFP sort-
ing is about 100-fold. This is similar to the Sca-1 enrich-
ment levels established in the published literature [3, 10].
While differences do not appear to exist on the level of
bone marrow HSC enrichment, we are examining whether
differences exist between antibody-mediated sorting and
GFP sorting in the intraembryonic tissue-generating HSCs
at the earliest stages of mouse development. This earliest
site, the aorta-gonads-mesonephros (AGM) region, gener-
ates the first adult repopulating HSCs at E10.5 [27].
Interestingly, in related studies, we reproducibly isolated
only 50% of HSCs from the AGM region using the Sca-1
antibody, but could isolate 100% of AGM HSCs using Ly-
6A GFP marker expression [30]. This supports the notion
that the Ly-6A GFP marker is more efficiently expressed
and identifies the Sca-1low-expressing population of HSCs
as they are being generated within the embryo. This may be
particularly useful in future studies of precursor-progeny
relationships and possible lineage relationships of HSCs
with endothelial cells.
Further to this point, when we used a lacZ marker
gene in the Ly-6A cassette, we found high-level β-galac-
tosidase expression in the mesonephros of the E11 AGM
but no expression in the dorsal aorta, the site where the
first AGM HSCs are generated [21]. HSC sorting proce-
dures based on the FDG substrate for β-galactosidase
were unsuccessful. However, we have found GFP-
expressing cells lining the walls of the dorsal aorta in 
Ly-6A GFP embryos, and these cells contained all the
adult repopulating HSC activity [30]. While both lacZ and
GFP marker gene expressions were found in the
mesonephros, only the GFP reporter was optimally
expressed in AGM HSCs. Thus, GFP expression from the
Ly-6A cassette in the G5 line of transgenic mice serves as
an excellent tool for HSC enrichment and for the localiza-
tion of the HSCs in the adult as well as the embryo.
Further transgenic studies will focus on the deletion map-
ping of HSC-specific transcriptional regulatory elements so
as to express exogenous genes only in HSCs. Combined
with inducible expression, the Ly-6A transgenesis will
allow for a better understanding of HSC regulation and
migration during each precise stage of development and
adult hematopoietic maintenance.
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